Reactome | HPGD dimer oxidises RvD1 to 17(S)-oxo-RvD1 and 8-oxo-17(S)-RvD1

HPGD dimer oxidises RvD1 to 17(S)-oxo-RvD1 and 8-oxo-17(S)-RvD1

Stable Identifier

R-HSA-9024766

Type

Reaction [transition]

Species

Homo sapiens

Compartment

cytosol

Synonyms

NAD(+) + resolvin D1 => 17-oxoresolvin D1 + H(+) + NADH, NAD(+) + resolvin D1 => 8-oxoresolvin D1 + H(+) + NADH

ReviewStatus

5/5

Locations in the PathwayBrowser

Expand all

General

SBML | | PDF

SVG | | PPTX | SBGN

HPGD dimer oxidises RvD1 to 17(S)-oxo-RvD1 and 8-oxo-17(S)-RvD1

Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Cytosolic, dimeric 15-hydroxyprostaglandin dehydrogenase (HPGD dimer), in the presence of NAD+, can oxidise 17(S)-resolvin D1 (RvD1) to the novel metabolites 17(S)-oxo-RvD1 and 8-oxo-17(S)-RvD1. The 17(S)-oxo transformation effectively inactivates RvD1 activity whereas the 8-oxo metabolite retains most of its RvD1 activity (Sun et al. 2007). The epimeric 17(R) aspirin-triggered form (AT-RvD1) was also found to be able to resist rapid inactivation.

Literature References

PubMed ID	Title	Journal	Year
17244615	Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation Serhan, CN, Campbell, E, Colgan, SP, Oh, SF, Petasis, NA, Gotlinger, K, Yang, R, Uddin, J, Sun, YP	J. Biol. Chem.	2007